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Introduction
α-Herpesviruses are a subfamily of the herpesviruses con-
taining closely related human and animal pathogens, including 
human herpes simplex virus 1 (HSV-1; cold sores, corneal 
blindness, and encephalitis) and important animal viruses such 
as the porcine pseudorabies virus (PRV) and bovine herpesvirus 1 
(BoHV-1; respiratory symptoms, abortions, and/or neurological 
symptoms). Many of the disease symptoms observed after 
 infection  with  α-herpesviruses are associated with their neuro-
tropic behavior, including their ability to establish lifelong cy-
cles of latency and reactivation in the peripheral nervous system 
of their host (Preston, 2000; Enquist et al., 2002). Primary rep-
lication of most α-herpesviruses occurs in epithelial cells of the 
upper respiratory tract. Sensory neurons of the trigeminal gan-
glion (TG) that innervate these epithelial cells are predominant 
target cells for HSV-1, PRV, and BoHV-1 (Gutekunst et al., 
1980; Ackermann et al., 1982; Croen et al., 1987).
Entrance of HSV and PRV in the axons of these sensory 
neurons is thought to be initiated by an interaction of the viral 
envelope glycoprotein D (gD) with its receptor nectin-1, fol-
lowed by fusion of the viral envelope with the axolemma, 
which is mediated by viral proteins gB, gD, gH, and gL (Haarr 
et al., 2001; Mata et al., 2001; Milne et al., 2001; Mettenleiter, 
2002; Richart et al., 2003; Spear and Longnecker, 2003). 
  Fusion of the viral envelope with the axolemma is followed by 
retrograde transport of the capsid and a part of the associated 
tegument to the cell nucleus by means of microtubule- associated 
fast axonal transport (Tomishima et al., 2001; Smith et al., 
2004; Luxton et al., 2005). After entry of the DNA into the nu-
cleus, either a full replication cycle is initiated, leading to the 
formation of new virions, or a latent infection is established 
(Jones, 2003). Newly produced virions, during primary infec-
tion or after reactivation, are transported in the anterograde di-
rection along the axon, followed by virus release at the axon 
terminus (Smith et al., 2001; Tomishima and Enquist, 2001, 
2002). Recent data indicate that virus egress in axons may not 
be limited to the axon terminus but also seems to occur at scat-
tered sites along the axon shaft in a manner that remains not 
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 α
-Herpesviruses constitute closely related neurotropic 
viruses, including herpes simplex virus in man and 
pseudorabies virus (PRV) in pigs. Peripheral sensory neu-
rons, such as trigeminal ganglion (TG) neurons, are pre-
dominant target cells for virus spread and lifelong latent 
infections. We report that in vitro infection of swine TG 
neurons with the homologous swine α-herpesvirus PRV 
results in the appearance of numerous synaptophysin-
positive synaptic boutons (varicosities) along the axons. 
Nonneuronal cells that were juxtaposed to these varicos-
ities became preferentially infected with PRV, suggesting 
that varicosities serve as axonal exit sites for the virus. Viral 
envelope glycoprotein D (gD) was found to be   necessary 
and sufﬁ  cient for the induction of varicosities. Inhibition of 
Cdc42 Rho GTPase and p38 mitogen-  activated protein ki-
nase signaling pathways strongly suppressed gD-induced 
varicosity formation. These data represent a novel aspect 
of the cell biology of α-  herpesvirus infections of sensory 
neurons, demonstrating that virus attachment/entry is as-
sociated with signaling events and neuronal changes that 
may prepare efﬁ  cient egress of progeny virus.
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fully understood (Tomishima and Enquist, 2002; Ch’ng and 
Enquist, 2005; Saksena et al., 2006).
Despite the obvious importance of TG neurons as predomi-
nant target cells and sites of latency/reactivation events for many 
α-herpesviruses, a detailed study of the interactions between 
α-herpesviruses and this pathogenetically important cell type has 
been hampered by the lack of easy-to-handle, homologous in 
 vitro systems. We recently established such a homologous in vitro 
two-chamber system, based on the “Campenot” system, to study 
the interaction between porcine TG neurons and the porcine 
α-herpesvirus PRV (Campenot, 1977; De Regge et al., 2006). 
Using this in vitro model, we report that PRV induces, via its gD 
envelope protein, the formation of presynaptic boutons (varicosities) 
along the axon shaft of infected TG neurons. Varicosities are 
swellings along neuronal axons where synaptic vesicles, mito-
chondria, and ER accumulate (Pannese, 1994). They are able to 
form synaptic contacts with contacting nonneuronal cells and 
other axons (Pannese, 1994), but they also seem to play an im-
portant role in nonsynaptic communication in the nervous system 
by the release of neurotransmitters directly in the extrasynaptic 
space (Zhu et al., 1986; Vizi et al., 2004). We observed that non-
neuronal cells aligning the axon shaft of infected TG neurons were 
frequently infected, and the fi  rst infected nonneuronal cells were 
almost invariably located in close proximity to the varicosities. 
This suggests that virus-induced varicosities may serve as axon 
exit sites for the virus to infect neighboring cells.
Results
Induction of varicosities along the axons 
of PRV-infected porcine TG neurons
The two-chamber system to study interactions of PRV with 
porcine TG neurons is mounted on a coverslip and consists of 
an inner chamber, in which the neuronal culture (composed of 
neuronal and nonneuronal cells) is seeded, and an outer chamber, 
and the two are separated from each other by a virus- and 
  medium-impermeable silicon barrier (De Regge et al., 2006). 
After 2–3 wk of cultivation of trigeminal neurons in the inner 
chamber, axonal outgrowth through the silicon barrier into the 
outer chamber was detected by light microscopy. Addition of 
2 × 10
6 plaque-forming units (PFUs) of PRV to the outer cham-
ber resulted in exclusive infection of trigeminal neuronal cell 
bodies in the inner chamber, as described previously (De Regge 
et al., 2006).
Surprisingly, axons of PRV-infected neurons (24 h after 
inoculation) showed a massive amount of bouton-like axonal 
swellings, which were rarely detected on axons of noninfected 
cell bodies (Fig. 1 A). Double immunofl  uorescent stainings 
  using a neuronal cell marker (neurofi  lament) and a marker for 
synaptic vesicles (synaptophysin; Fig. 1 B) confi  rmed that the 
swellings are presynaptic boutons, also called varicosities. 
  Labeling of the PRV-induced varicosities with FM1-43, a fl  uo-
rescent marker for fi  ring neurons, indicated that the synaptic 
transmission at the varicosities is intact (Fig. 1 C). Varicosities 
were formed between 3 and 6 h after inoculation and were 
 observed  in  >70% of the axons at both early (6 h after inoculation) 
and late (24 h after inoculation) stages of infection. In mock-
treated cultures, only 12% of the axons showed varicosities 
(Fig. 1 D).
A PRV strain that lacks the gD envelope 
protein is unable to induce the formation 
of varicosities
Varicosities could be induced by UV-inactivated PRV (Fig. 2 B), 
indicating that the trigger for varicosity formation occurs early 
in infection, either during virus attachment or entry, before the 
Figure 1.  Induction of varicosities along the 
axons of PRV-infected porcine TG neurons. 
(A) Confocal images of TG neurons in the inner 
chamber of mock- or PRV-infected two-chamber 
models at 24 h after inoculation, stained for 
the neuronal marker neuroﬁ  lament 68 (Texas 
red) and PRV antigens (FITC).   Arrows point to 
varicosities. Bar, 20 μm. (B and C) Confocal 
images of varicosities in the inner chamber of 
a two-chamber model at 24 h after inocula-
tion with 2 × 10
6 PFUs of WT-PRV and double 
stained for neuroﬁ  lament (Texas red) and the 
synaptic vesicle marker synaptophysin (FITC; B) 
or labeled with FM1-43 (C). Bars, 5 μm. 
(D) Percentage of axons with varicosities in 
mock-treated or PRV-inoculated two-chamber 
models (3, 6, and 24 h after inoculation). Data 
shown represent means ± SEM of triplicate 
  assays. Percentages indicated by the same 
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onset of viral protein production. To assess whether induction 
of varicosities involves the virus entry–essential viral envelope 
proteins gB or gD, isogenic stocks of phenotypically and geno-
typically gBnull- and gDnull-PRV were prepared. Virus stocks 
were obtained by inoculating phenotypically complemented 
gBnull- and gDnull-PRV stocks on noncomplementing swine 
testicle cells and harvesting the progeny virus from the culture 
supernatant. SDS-PAGE and Western blotting confi  rmed that 
gB and gD were absent from the gBnull- and gDnull-PRV 
stocks, respectively (Fig. 2 A). Relative virus particle numbers 
in the gBnull- and gDnull-PRV stocks were determined as de-
scribed previously (Qie et al., 1999; Cheshenko and Herold, 
2002), by comparing the amount of gB and gD in the deleted 
stocks and in serial dilutions of wild-type (WT)–PRV stock by 
optical densitometry after Western blotting, as described in 
  Materials and methods.
Virus quantities of gBnull- and gDnull-PRV correspond-
ing to the amount of particles present in 2 × 10
6 PFUs of WT-
PRV were added to the outer chamber of the two-chamber 
system, and the percentages of axons displaying varicosities 
were determined at 24 h after inoculation. Varicosity induction 
by the gBnull virus was comparable to that of WT-PRV (68 vs. 
72%, respectively; Fig. 2 B). However, when axons were inocu-
lated with the gDnull virus, the percentage of axons with vari-
cosities was comparable to that of the mock-treated control 
(14 vs. 12%, respectively). As expected, neither null virus in-
duced infection of the TG neurons, as neither was able to enter 
the cells (unpublished data). To exclude the possibility that the 
lack of synapse induction by the gDnull virus was due to an in-
suffi  cient amount of virus added, the experiment was repeated 
with 10-fold more gDnull virus, and similar results were ob-
tained (unpublished data). In conclusion, a gDnull-PRV strain is 
unable to induce the formation of varicosities, suggesting that 
virion gD triggers this process.
Recombinant PRV-gD protein 
and nectin-1–speciﬁ  c antibodies 
induce the formation of varicosities
To address whether gD alone could induce varicosities, various 
concentrations of a truncated, soluble form of PRV-gD (PRV-gDt; 
Connolly et al., 2001) were added to the outer chamber of the 
in vitro model and incubated with the axons for 24 h, followed by 
neurofi  lament staining and quantifi  cation of the number of axons 
that showed varicosities. Incubation resulted in a dose-dependent 
increase in the number of axons carrying varicosities (Fig. 3 A). 
The addition of 5 μg PRV-gDt/ml or more resulted in 60–70% 
axons with varicosities (Fig. 3 A), which is comparable to the 
percentages observed by the addition of WT-PRV.
Entry of α-herpesviruses, like HSV-1 or PRV, into sensory 
neurons is believed to be mediated by interaction of viral envelope 
protein gD with nectin-1 (Haarr et al., 2001; Mata et al., 2001; 
Milne et al., 2001; Richart et al., 2003). Therefore, we hypoth-
esized that gD-mediated induction of varicosities results from an 
interaction with nectin-1. To test this hypothesis, we determined 
whether addition of various concentrations of an   antibody that 
binds the ectodomain of nectin-1 (CK6;   Krummenacher et al., 
2000) was also able to trigger varicosity formation. As with 
soluble gD, a 24-h incubation period with monoclonal anti–
  nectin-1 antibody in the outer chamber again resulted in a clear 
dose-dependent response. For antibody CK6, 100 μg/ml caused 
Figure 2.  A PRV strain that lacks the gD envelope protein is unable to 
induce the formation of varicosities. (A) Western blots of equal volumes 
of a serial dilution of a WT-PRV stock with known titer (PFU/ml) and 
  gBnull- and gDnull-PRV stocks, developed with anti-gB antibodies (blot A) 
or anti-gD antibodies (blot B). (B) Percentage of axons with varicosities 
24 h after inoculation of two-chamber models with an amount of UV-
  inactivated WT-PRV, gBnull-PRV, gDnull-PRV, or WT-PRV particles equiva-
lent to 2 × 10
6 PFUs of WT-PRV. Data shown represent means ± SEM of 
triplicate assays. Percentages indicated by the same letter do not signiﬁ  -
cantly differ (α = 0.05).
Figure 3.  Recombinant gD protein and nectin-1–speciﬁ  c  antibodies 
induce formation of varicosities in TG neurons. Percentage of axons with 
varicosities in mock-treated two-chamber models or at 24 h after addition 
of recombinant soluble PRV-gD (0.001–10 μg/ml; A), a nectin-1–speciﬁ  c 
  antibody (0.1–100 μg/ml CK6) or an isotype-matched control antibody 
(100 μg/ml 13D12; B) to the outer chamber of two-chamber systems. Data 
shown represent means ± SEM of triplicate assays. Percentages indicated 
by the same letter do not signiﬁ  cantly differ (α = 0.05).JCB • VOLUME 174 • NUMBER 2 • 2006  270
varicosities to form on 70% of the axons (Fig. 3 B), again similar 
to the percentage observed by addition of WT-PRV. The addition 
of 100 μg/ml of CK41, a monoclonal antibody directed against 
another epitope on the ectodomain of nectin-1, also resulted in 
induction of varicosity formation (unpublished data). The addi-
tion of 100 μg/ml of an isotype-matched control IgG1 antibody 
(13D12) did not result in an increase in the percentage of axons 
with varicosities compared with mock-treated two-chamber   
systems. In conclusion, addition of recombinant gD or anti–
  nectin-1 antibodies to the axons of TG neurons is suffi  cient to 
induce the formation of varicosities.
Cdc42 Rho GTPase and p38 MAPK 
signaling pathways are involved in 
𝗂-herpesvirus–induced varicosity formation
Nectin-1 has been shown to signal via small Rho GTPase sig-
naling pathways in MDCK and L cells (Fukuhara et al., 2003, 
2004). In addition, Cdc42 Rho GTPase and MAPK signaling 
pathways have been suggested to be involved in varicosity for-
mation (Hu et al., 2004; Nakata et al., 2005; Udo et al., 2006). 
Therefore, to determine which signaling pathways may be in-
volved in PRV-induced varicosity formation, the effect of inhib-
itors of different signaling pathways (Rho GTPase and MAPK 
signaling pathways) were tested for their effect on PRV-induced 
varicosity formation. A broad-range inhibitor of small Rho 
  GTPase signaling (50 ng/ml Clostridium diffi  cile toxin B) as well 
as specifi  c inhibitors of Rho (30 μM Y27632), Rac1 (100 μM 
Rac1 inhibitor), or Cdc42 (2 μM secramine A) signaling were 
used. The role of MAPK signaling was examined by using in-
hibitors for extracellular signal–regulated kinase (ERK) signaling 
(10  μM U0126), JNK signaling (20 μM JNK inhibitor II), 
and p38 signaling (20 μM SB203580). General inhibition of 
small Rho GTPase signaling as well as specifi  c inhibition of 
Cdc42 signaling suppressed varicosity formation to a level that 
was not signifi   cantly different from mock-infected cultures, 
whereas specifi  c inhibition of Rho or Rac1 signaling had no ob-
vious effect (Fig. 4 A). Inhibition of p38 MAPK signaling also 
resulted in a strong reduction of varicosity formation, in con-
trast to inhibition of ERK or JNK MAPK signaling (Fig. 4 B). 
These data suggest that PRV activates varicosity formation via 
signaling pathways dependent on Rho GTPase (in particular 
Cdc42) and MAPK (in particular p38).
PRV-gD–induced varicosities serve 
as axonal exit sites for PRV
The inner chamber of the TG cultures does not consist solely of 
TG neurons but also contains many nonneuronal cells, which 
form a monolayer in the inner chamber, in which the TG neu-
rons are dispersed. When the inner chamber of TG neuronal 
cultures was stained for PRV antigens at 24 h (or later) after in-
oculation with WT-PRV in the outer chamber, viral antigen–
positive nonneuronal cells were observed aligning the axons of 
PRV-infected TG neurons. Interestingly, single-infected non-
neuronal cells were almost invariably (88%) juxtaposed to vari-
cosities (Fig. 5). Spread of PRV from varicosities to neighboring 
nonneuronal cells could not be blocked by neutralizing anti-
bodies (unpublished data), indicating that it occurs via direct 
cell–cell spread. These data indicate that egress of infectious vi-
rus along the axon shaft occurs specifi  cally at varicosities.
Discussion
The neurotropic behavior of α-herpesviruses is of crucial impor-
tance for the pathogenicity of these viruses, allowing them to es-
tablish lifelong latency and cause central nervous disorders, 
encephalitis, and recurrent disease. Neurons of the TG repre-
sent crucial target neurons for many α-herpesviruses, including 
HSV-1, PRV, and BoHV-1. The exact cell biology underlying 
the   interactions of α-herpesviruses with neurons, especially TG 
neurons, remains far from fully understood. Here, we used an 
in vitro model to study the interaction of an α-herpesvirus (PRV) 
with TG neurons of its corresponding host (the pig). We report 
a novel aspect of the cell biology of α-herpesvirus interaction with 
TG neurons. We found that the interaction of PRV with axons of 
porcine TG neurons triggers the formation of synaptic boutons 
(varicosities) along the axons of these neurons. To our knowl-
edge, this is the fi  rst paper reporting that a virus infection stimu-
lates the formation of varicosities. In addition, we show that the 
viral envelope protein gD is responsible for the induction of 
varicosities, probably via an interaction with the entry receptor 
  nectin-1 or nectin-like molecules; that Cdc42 Rho GTPase and 
p38 MAPK signaling pathways are involved; and that virus egress 
along the axon shaft of infected TG neurons occurs frequently 
and specifi  cally at these varicosities. These observations open the 
intriguing possibility that the virus has evolved a strategy to facil-
itate spread of progeny virus from TG neurons by inducing vari-
cosities at the time of virus attachment and entry in axons.
Figure 4.  Cdc42 Rho GTPase and p38 MAPK signaling pathways are in-
volved in 𝗂-herpesvirus–induced varicosity formation. Percentage of axons 
with varicosities in mock-treated two-chamber models or at 16 h after incu-
bation with an amount of UV-inactivated PRV particles equivalent to 2 × 10
6 
PFUs of WT-PRV, in the presence of inhibitors directed against (A) small Rho 
GTPases (C. difﬁ  cile toxin B), Rho (Y27632), Rac1 (Rac1 inhibitor), or 
Cdc42 (secramine A) or (B) ERK (U0126), JNK (JNK inhibitor II), or p38 
MAPK signaling (SB203580). Data shown represent means ± SEM of trip-
licate assays. Percentages indicated by the same letter do not signiﬁ  cantly 
differ (α = 0.05).α-HERPESVIRUS GD–INDUCED NEURONAL VARICOSITIES • DE REGGE ET AL. 271
An important question is how exactly PRV induces the 
formation of varicosities in porcine TG neurons. We found that 
addition of UV-inactivated PRV (which is able to adhere to and 
penetrate cells but does not start up viral gene expression) or 
a strain of PRV that lacks the envelope protein gB (which is able 
to adhere to but not penetrate cells) to the axons of TG neurons 
still resulted in varicosity formation. This shows that varicosity 
formation is triggered during virus attachment to the axons and 
does not require infection. Interestingly, a PRV strain that lacks 
gD in its envelope (which is also able to adhere to but not 
  penetrate cells) did not induce varicosities, demonstrating an 
  involvement of gD in this process. Moreover, addition of re-
combinant soluble gD to the axons of TG neurons was suffi  cient 
to trigger varicosity formation. Together, these data indicate 
that interaction of PRV envelope protein gD with axons of TG 
neurons during virus attachment provides the trigger necessary 
for subsequent formation of varicosities.
How does the interaction of gD with the surface of axons 
lead to varicosity formation? Three classes of receptors for 
α-herpesvirus gD proteins have been described to date: one 
  belongs to the tumor necrosis factor receptor family (i.e., herpes 
virus entry mediator), another class belongs to the immuno-
globulin superfamily (including nectin-1 and -2), and another type 
of receptor consists of modifi  ed heparan sulfate (Montgomery 
et al., 1996; Cocchi et al., 1998; Geraghty et al., 1998; Warner 
et al., 1998; Shukla et al., 1999; Spear and Longnecker, 2003).
  Nectin-1 has been suggested to serve as the gD receptor 
  onsensory neurons (like TG neurons) for both HSV and PRV 
(Haarr et al., 2001; Mata et al., 2001; Milne et al., 2001; Richart 
et al., 2003). Nectins are cell adhesion molecules that play impor-
tant roles in the formation of many types of cell–cell junctions, 
  including synapses (Takai et al., 2003). We found that, for both 
of two different nectin-1–specifi  c antibodies, addition to the 
axons of TG neurons (as a surrogate ligand for nectin-1 instead 
of gD) resulted in the formation of varicosities. This suggests 
that the interaction between gD and nectin-1 on the axons of 
TG neurons provides the trigger that ultimately culminates in 
the formation of varicosities. This would be consistent with ob-
servations made by Mizoguchi et al. (2002), who showed that 
stimulation of nectin-1 in mouse hippocampus neurons resulted 
in a substantial increase in the number of  synaptophysin- positive 
varicosities. However, at present, we cannot rule out the pos-
sibility that other nectins or nectin-like molecules, in addition 
to or instead of nectin-1 might be relevant to the gD-mediated 
induction of varicosities. Porcine nectin-1 is thus far the only 
porcine entry receptor that has been reported for PRV (Milne 
et al., 2001), but different human forms of the nectin family, like 
nectin-1, nectin-2, and necl-5 (poliovirus receptor), have been 
reported to be gD-binding entry receptors for PRV (Geraghty 
et al., 1998, Connolly et al., 2001).
In addition to a crucial role of the interaction between gD 
and nectin-1 and/or other members of the nectin family for the 
PRV-induced formation of varicosities, we also found that 
Cdc42 Rho GTPase as well as p38 MAPK signaling pathways 
are involved. Inhibition of these signaling pathways strongly 
suppressed PRV-induced varicosity formation. These data are 
consistent with recent indications that the Cdc42 (but not Rho 
or Rac) signaling pathway is involved in serotonin-induced var-
icosity formation in sensory neurons (Udo et al., 2006) and that 
MAPK signaling pathways, such as p38, may play important 
roles during development of varicosities (Hu et al., 2004;  Nakata 
et al., 2005). Further in line with our current observations, it has 
Figure 5.  Varicosities serve as axonal exit 
sites for PRV. (A) Confocal images of TG neu-
ronal cultures in the inner chamber of PRV-
  infected two-chamber systems at 24 h after 
inoculation and stained for neuroﬁ  lament 68 
(Texas red), PRV antigens (FITC), and nuclei 
(Hoechst 33342). Arrows point to varicosities. 
Bars, 5 μm. (B) Graph shows the percentage 
of single-infected cells that are juxtaposed to 
varicosities, calculated compared with the to-
tal number of single-infected cells. Data shown 
represent means ± SEM of four assays.JCB • VOLUME 174 • NUMBER 2 • 2006  272
been reported that nectin-1 may signal through Rho GTPase 
pathways, such as Cdc42 and Rac, in MDCK and L cells 
(  Fukuhara et al., 2003, 2004). Our current fi  ndings that an 
α-herpesvirus, via its envelope gD, stimulates formation of 
  synaptophysin-positive varicosities and that this process in-
volves Cdc42 and p38 MAPK signaling may, therefore, consti-
tute a valuable tool to further dissect the underlying molecular 
mechanisms of varicosity formation and the role of nectin-1 and 
other nectin-like molecules herein.
α-Herpesviruses have evolved different strategies to mod-
ulate the host cell to facilitate virus spread, such as gE-mediated 
targeting of virus particles to cell junctions for spread in polar-
ized cells (Collins and Johnson, 2003; Wisner and Johnson, 
2004) and intercellular virus spread via US3-induced actin rear-
rangements and cell projections (Favoreel et al., 2005).   Although 
future in vivo experiments will be required to fully delineate the 
consequences of our current fi  ndings for α-herpesvirus patho-
genesis, we propose that induction of axonal varicosities by 
PRV early in infection of TG neurons may be part of the viral 
strategy to later promote effi  cient spread.
Varicosity-mediated spread may lead to egress of 
α-herpesviruses along the axon shaft but may also enhance 
spread of the virus to mucosal surfaces, a crucial step in 
α-herpesvirus pathogenesis. Trigeminal sensory nerve fi  bers 
may extend beyond the basement membrane to nearly reach the 
epithelial surface (Finger et al., 1990). These intraepithelial ter-
minal regions of the axon have penetrated the basement mem-
brane and lost their myelin sheath and are prone to varicosity 
formation. Strings of varicosities have been reported to occur 
in these intra  epithelial terminal areas of the TG axons in vivo 
(Kondo et al., 1992, Ibuki et al., 1996).
The exact function of α-herpesvirus egress along the 
  entire length of axon shafts is not understood, but PRV egress 
along axons shafts has clearly been demonstrated in vivo in rats 
and was found to occur via direct cell–cell spread, which is in 
line with our current fi  ndings (Tomishima and Enquist, 2002). 
Interestingly, this axonal egress in vivo as well as in vitro was 
found to occur at scattered sites (Tomishima and Enquist, 2002; 
Ch’ng and Enquist, 2005). Given our current fi  nding that axonal 
egress almost exclusively occurs at varicosities, we hypothesize 
that these scattered sites may correspond to varicosities. In fur-
ther support of this, a recent paper suggests that axonal egress 
of HSV-1 occurs via varicosities in human fetal dorsal root gan-
glia neurons in vitro (Saksena et al., 2006). Transport of progeny 
herpesvirus particles in the axon is believed to either occur via 
 secretory vesicles containing fully matured virions or as subvirion 
particles, where capsids and envelope proteins are transported 
separately and only assemble into mature virions at synapses 
(Tomishima and Enquist, 2002). In our opinion, both scenarios 
can lead to specifi  c axonal egress at varicosities, as these struc-
tures have been shown to accumulate secretory vesicles and may 
also constitute functional synapses (Santos et al., 2001).
Virus-induced varicosities endured for at least several 
days (>72 h; unpublished data). It remains to be determined 
whether and when they disappear after the initial infection. 
  Although speculative at this time, it is possible that the virus is 
able to reinduce varicosities over and over again when needed 
during latency/reactivation cycles. Reactivations can lead to 
production and release of infectious virus, which in turn may 
attach to and enter new TG neurons, thereby inducing varicosity 
formation and further promoting virus spread.
It is possible that virus-induced formation of varicosities 
has consequences beyond virus spread. At least a subpopulation 
of synaptophysin-positive varicosities function as sites for neuro-
transmitter release along the axon of different types of neurons 
(Kohara et al., 2001; Pennuto et al., 2002; Morgenthaler et al., 
2003). In line with this, we found that the virus-induced vari-
cosities stain positive for FM1-43, characteristic of intact syn-
aptic transmission. Synaptic transmission was also intact in 
varicosities induced by UV-inactivated PRV or recombinant gD 
of PRV (unpublished data). In this context, it is interesting to 
note that α-herpesvirus infections have been associated with 
hyperexcitability of neurons, possibly involved in acquired 
  epilepsy after HSV encephalitis (Chen et al., 2004). Future in-
vestigations will be designed to further unravel whether the 
PRV-induced formation of synaptically effective varicosities 
lead to changes in excitability of neurons.
In conclusion, we have found that entry of an α- herpesvirus 
in neurons of the TG of its natural host is associated with the in-
duction of synaptic varicosities along the axons. Virus-  induced 
varicosity induction depends on viral envelope protein gD and 
on Cdc42 Rho GTPase and p38 MAPK signaling pathways, and 
the virus uses the varicosities as axonal egress sites to spread to 
neighboring cells.
Materials and methods
Viruses and cells
WT-PRV strain Becker, WT-PRV strain Kaplan, and isogenic deletion mutants 
gBnull and gDnull were used (Kaplan and Vatter, 1959; Card et al., 1990; 
Rauh and Mettenleiter, 1991; Rauh et al., 1991). Stocks of phenotypically 
complemented gBnull and gDnull viruses were grown on gB- and gD-
  complementing cell lines. Stocks of phenotypically and genotypically gBnull 
and gDnull viruses were produced by a single round of infection of pheno-
typically complemented gBnull and gDnull viruses on noncomplementing 
swine testicle cells and harvesting the progeny virus from the supernatant.
Antibodies, proteins, and inhibitors
Monoclonal mouse anti-gB (1C11) and anti-gD (13D12) antibodies and 
polyclonal porcine FITC-labeled anti-PRV antibodies were produced as pre-
viously described (Nauwynck and Pensaert, 1995). The monoclonal neu-
ronal markers mouse anti–neuroﬁ  lament 68 and rabbit anti–  neuroﬁ  lament 
200 and the monoclonal synapse marker mouse anti-synaptophysin 
were purchased from Sigma-Aldrich. FITC- and Texas red–labeled goat 
anti–mouse antibodies and Texas red–labeled goat anti–rabbit antibodies 
were obtained from Invitrogen. Biotinylated sheep anti–mouse IgG and 
a   streptavidin-biotinylated horseradish peroxidase complex were pur-
chased from GE Healthcare. Inhibitors C. difﬁ  cile toxin B, Y27632, Rac1 
inhibitor (NSC23766), U0126, SB203580, and JNK inhibitor II were ob-
tained from Calbiochem. Secramine A was used as a speciﬁ  c inhibitor for 
Cdc42, as described previously (Pelish et al., 2006). PRV-gDt (Connolly 
et al., 2001) and two monoclonal mouse anti–human antibodies directed 
against different epitopes on the ectodomain of nectin-1 (CK6 and CK41; 
  Krummenacher et al., 2000) were used.
Quantiﬁ  cation of gBnull- and gDnull-PRV stocks
The number of virus particles in the gBnull and gDnull stock was estimated 
by optical densitometry, as described previously (Qie et al., 1999; 
  Cheshenko and Herold, 2002). Equal volumes of a serial dilution of a WT-
PRV stock with a known titer and of stocks of the genotypically and pheno-
typically gBnull- and gDnull-PRV strains were subjected to SDS-PAGE under 
nonreducing conditions and Western blotting, followed by detection of 
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  secondary sheep anti–mouse antibodies, streptavidin-biotinylated horse-
radish peroxidase complex, and 3,3′-diaminobenzidine (Sigma-Aldrich) 
for gB or enhanced chemiluminescence (ECL Western blotting analysis 
  system; GE Healthcare) for gD. All antibodies were diluted in PBS with 
0.1% Tween-20 (Sigma-Aldrich), and blots were washed three times in PBS 
with 0.1% Tween-20 in between different antibody incubations and after 
the   ﬁ  nal antibody incubation. Relative amounts of gB and gD in the gDnull 
and gBnull stock, respectively, were compared with the amount of gB and 
gD present in the WT stocks using Quantity One 1-D analysis software 
(Bio-Rad Laboratories).
Immunoﬂ  uorescence staining procedures
After being washed in PBS, neuronal cultures in the inner and outer cham-
ber of the two-chamber model were ﬁ  xed in 100% methanol for 20 min at 
−20°C, except for cultures that were labeled for synaptophysin, which 
were ﬁ   xed using 4% paraformaldehyde in PBS for 10 min and subse-
quently permeabilized in 0.2% Triton X-100 (Sigma-Aldrich) in PBS for 
2 min. All antibodies were diluted in PBS to 1:100. Cells were incubated 
with each antibody for 1 h at 37°C and were washed two times in PBS in 
between all incubation steps and after the last incubation step. When nec-
essary, nuclei were stained using 10 μg/ml Hoechst 33342 (Invitrogen) 
for 10 min before the ﬁ  nal washing steps.
Cultivation, inoculation, and analysis of primary TG neuronal cultures 
in a two-chamber model
Porcine TG neurons were obtained as described previously (Geenen et al., 
2005) and seeded in an in vitro model based on the “Campenot” system 
(Campenot, 1977), which allows simulation of the in vivo route of neuronal 
infection (De Regge et al., 2006). In brief, porcine TG were excised from 
4–6-wk-old piglets and dissociated by enzymatic digestion with 0.2% col-
lagenase A (Roche). The harvested cells were resuspended in culture 
  medium (basic culture medium without glutamine) and supplemented with 
30 ng/ml nerve growth factor (Sigma-Aldrich) and seeded in the inner 
chamber of an in vitro two-chamber model. The two-chamber system con-
sists of a polyallomer tube that is ﬁ  xed with silicon grease on a collagen-
coated cover glass inserted in a 6-well plate (Nunc). The inside of the tube 
forms the inner chamber, and the outside forms the outer chamber. The sili-
con barrier prevents diffusion of medium or virus from one chamber to the 
other (De Regge et al., 2006). 1 d after seeding, cultures were washed 
with RPMI (Invitrogen) to remove nonadherent cells and, from then on, cul-
ture medium was changed three times a week.
After 2–3 wk of cultivation, when clear axon growth could be 
observed in the outer chamber, the outer chamber was inoculated with 
2 × 10
6 PFUs of WT-PRV or with an equivalent number of UV-inactivated, 
  gBnull- or gDnull-PRV particles. In some experiments, the outer chamber 
was incubated with soluble PRV-gD (ranging from 0.001 to 10 μg/ml), 
with antibodies directed against nectin-1 (CK6, ranging from 0.1 to 
100 μg/ml, or CK41, 100 μg/ml) or with an isotype-matched (IgG1) 
  control antibody directed to the viral envelope gD (100 μg/ml 13D12; 
  Nauwynck and Pensaert, 1995; Krummenacher et al., 2000).
The percentage of axons showing varicosities after different treat-
ments was determined by ﬂ  uorescent labeling using anti-neuroﬁ  lament an-
tibodies and examination of 30 axons with outgrowth in the outer chamber 
of different two-chamber models for the presence of multiple (>5/250 μm 
axon) swellings that were at least 1.5 times the diameter of the axon. Data 
shown represent means ± SEM of triplicate assays.
FM1-43–labeling procedure
The ﬁ  ring capacity of the induced varicosities was determined by loading 
the neurons with FM1-43 (Invitrogen), basically as described before 
(Mizoguchi et al., 2002). After 2–3 wk in culture, the outer chamber was 
treated for 24 h with 2 × 10
6 PFUs of WT-PRV, an equivalent number of 
UV-inactivated PRV particles, or 10 μg/ml soluble PRV-gD. Then, the inner 
chamber was washed with Hanks’ balanced salt solution supplemented 
with 100 mM KCl and 1.5 mM CaCl2 for 1 min. The neurons were incu-
bated with culture medium containing 100 mM KCl and 20 μM FM1-43 
for 10 min. After being washed with Hanks’ balanced salt solution for 
15 min, cultures were mounted on coverslips without ﬁ  xation and exam-
ined by confocal microscopy.
Inhibitor studies
To examine the effect of different inhibitors on varicosity formation, both 
the inner and outer chamber of the two-chamber system were pretreated 
with culture medium supplemented with the respective inhibitor for 2 h. 
  Afterward, the outer chamber was incubated with UV-inactivated PRV 
  particles equivalent to 2 × 10
6 PFUs of WT-PRV in the presence of the 
  inhibitor. After an incubation period of 16 h, the two-chamber system was 
methanol ﬁ  xed and stained, and the percentage of axons showing varicos-
ities was determined as described (see Cultivation, inoculation, and 
analysis…).
Quantiﬁ  cation of single-infected cells juxtaposed to varicosities
Single-infected cells were scored as juxtaposed to a varicosity when the 
signal of the viral antigens (FITC signal) contacted the varicosity (Texas red 
signal), as seen in two-chamber models ﬁ  xed at 24 h after inoculation with 
2 × 10
6 PFUs of WT-PRV and stained with polyclonal FITC-labeled anti-PRV 
antibodies and the neuronal cell marker anti–neuroﬁ  lament 68 (Texas red). 
50 single-infected cells were analyzed, and data shown represent the 
mean ± SEM of four assays.
Confocal microscopy
Stainings were analyzed on a laser-scanning spectrum confocal system 
(TCS SP2; Leica Microsystems GmbH) linked to a microscope (DM IRBE; 
Leica Microsystems GmbH). Images were taken using a 63× oil objective 
(NA 1.40–0.60) at room temperature and using confocal acquisition soft-
ware (Leica Microsystems GmbH). Adjustments of brightness and contrast 
were applied to the entire images and were done using Photoshop (Adobe).
Statistics
The mean percentages of axons displaying varicosities after the different 
treatments were compared with an analysis of variance and a least signiﬁ  -
cant difference post hoc test for a multiple comparison of means (α = 0.05).
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